Skip to content
ASYNCHRONOUS TELEMEDICINE SOLUTIONS
- GoGoHealth – Protocol Authoring Engine, API, and Protocol Library
- Zipnosis –Fabric Health
- Healthtap $30 Inbox Consults
- Healthpartners-VirtuWell $40/visit or copay (more service than product)
- Sharecare ASKMD
- CaptureProof
- Lumiata
- Symptify.com
- Ada Health
- Buoy Health
- Evernorth Acquires Bright.md Technology Platform, Enhances MDLIVE’s Virtual Care Experience for Patients and Clinicians | Evernorth– MDLIVE
- 98point6
- Previsit.ai and PostVisit.ai
- MoCA (online/remote)
10-15 min
Strong (sensitivity ~86%, specificity ~88% for MCI)tandfonline
Gold-standard domains; widely accepted; strong evidence base; remote adaptations validated
Requires clinician administration (even remotely); training required ($125/person, 2-yr certification); not fully unsupervisedmyagsonline.americangeriatrics
Free test, but training $125/personmyagsonline.americangeriatrics
- SAGE (Self-Administered Gerocognitive Exam)
10-15 min
Strong (superior to MMSE for MCI→dementia conversion)pmc.ncbi.nlm.nih
Free; paper or online; self-administered; validated at scale; excellent for community screening
Requires printing/scoring or digital adaptation; age/education norms critical; not as brief as ultrabrief options
Freeverywellhealth
- UCSF Brain Health Assessment (BHA)
~10 min cognitive + 3 min informant
Very strong (AUC 0.94, sensitivity 84% at 85% specificity)pmc.ncbi.nlm.nih
Best published MCI accuracy; combines cognitive + informant data; tablet/PC compatible
Primarily research tool; not widely commercially available; requires setup; longer than ultrabrief
Research use (no commercial pricing published)memory.ucsf
- BrainCheck
~21 min
Good (distinguishes MCI/dementia/normal; remote = in-person performance)todaysgeriatricmedicine+1
FDA-cleared; clinic + remote; automated scoring/reports; CPT-reimbursable in US; enterprise platform
Longer duration; subscription model (not per-test); requires institutional contract
Subscription-based (providers; no per-test cost to patients)axios+1
- Cogstate Brief Battery (CBB)
~15-20 min
Moderate (optimized cutoffs: ~70% sens/spec for MCI; at-home validated)pmc.ncbi.nlm.nih+1
Strong research pedigree; at-home validated; good for longitudinal monitoring; multiple cognitive domains
Conventional cutoffs less sensitive; requires platform access; moderate accuracy vs BHA/MoCA
Research license: departmental/institutional pricing (150 assessments ~£1,500)cambridgecognition+1
- Creyos (Cambridge Brain Sciences)
2-3 min/task; 15-20 min typical battery
Emerging (limited MCI-specific peer-reviewed data vs full battery validation)karger+1
Very short individual tasks; flexible battery; online; automated; can configure ultrabrief
Less published MCI diagnostic accuracy vs MoCA/BHA; single tasks sacrifice depth
$79-150/assessment (clinical use)henriettapsych+1
- M-CogScore
<5 min
Good (comparable to MMSE-2 for impaired cognition; remote self-administered)pmc.ncbi.nlm.nih+1
Fastest validated option; fully unsupervised; web-based; MMSE-comparable
Newer tool; limited large-scale MCI-specific data; may need proprietary access
Not publicly disclosed (research/commercial)
- Food for the Brain Cognitive Function Test (CFT)
~30 min (cognitive + lifestyle)
Limited public data (validated vs memory-clinic tests per developer; “almost perfect correlation”)foodforthebrain+1
Free; holistic (cognitive + lifestyle DRI); large user base (370K+); educational feedback
Long duration; limited peer-reviewed MCI sensitivity/specificity; not for rapid triage
Free online test; optional blood biomarker kits £185-240foodforthebrain+1
- Punto Health PuntoTest
Not disclosed (likely <10 min)
Emerging (AI speech-based; in use at NHS/Spanish hospitals; limited public peer-reviewed MCI data)investinspain+1
AI speech-based; remote; integrated care platform; used in large screening programs (1,500+ in Barcelona pharmacies)
Very limited published MCI diagnostic accuracy; newer platform; requires platform access
Not publicly disclosed (B2B healthcare platform)htworld
- Ultrabrief digital biomarkers (research prototypes)
2-3 min
Emerging (2024-2026 publications; AUCs “good” for MCI vs normal)pmc.ncbi.nlm.nih+1
Fastest possible; memory + attention/RT paradigms; designed for primary care scale
Not commercially available yet; limited head-to-head vs MoCA; research-stage
Research tools (not commercially available)
- CANTAB Connect Research
Variable (depends on battery selection)
Strong (extensive AD/MCI research use; validated across clinical stages)investing+1
Gold-standard research tool; large normative data; flexible batteries; remote capable
Requires institutional license; longer batteries for full coverage; cost
Departmental license (institutional pricing; grants provide 150 assessments ~£1,500)cambridgecognition+1
- Linus Health DCR / Core Cognitive Evaluation
~3 min (DCR); ~7 min (full CCE with speech)
Strong — 91% accuracy for MCI, 95% for early dementia vs gold-standard 3-hr neuropsych eval; outperforms MMSE; detects 79% of cases MMSE misclassifies
FDA Class II listed; AI-enhanced drawing + speech biomarkers; ~3 min self-administered; EHR integration (Epic); less racial/ethnic bias than MMSE; remote (Anywhere) + in-clinic; 20+ peer-reviewed validation studies; captures 50+ graphomotor metrics invisible to paper tests
Proprietary platform (subscription/enterprise); iPad-based (not browser-only); per-test pricing not public; requires institutional contract; newer than MoCA in clinical adoption
Enterprise subscription (not publicly disclosed; B2B health system model)